Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (diarrhoea - Huys2002) and clinical sources (wound - CCUG)
|
Opt. T: 30-37℃
NaCl 0.5-2%: 0(+)
NaCl 3-5%: 3(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R(10; disc)
Augmentin: R(30; disc)
ampicillin: R(10; disc)
aztreonam: S(30; disc)
carbenicil: R(100; disc)
piperacillin: R(100; disc)
piper-taz: R(110; disc)
ticarcillin: R(75; disc)
tica-clav: Var(MIC50): 85; disc), MIC90: Var(85; disc
imipenem: S(10; disc)
|
cefepime: S(30; disc)
cefixime: Sens
cefoperazone: Sens
cefotaxime: S(30; disc)
cefoxitin: Res
ceftazidime: Sens
cefuroxime: Sens
cephalothin: R(30; disc)
|
amikacin: S(30; disc)
gentamicin: S(10; disc)
kanamycin: Var(MIC50): 30; disc), MIC90: Var(30; disc
netilmycin: S(30; disc)
tobramycin: R(10; disc)
|
erythromycin: R(15; disc)
|
ciprofloxacin: S(5; disc)
levofloxacin: Sens
norfloxacin: S(10; disc)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
minocycline: Sens
tetracycline: S(30; disc)
|
|
|
chloramphenicol: S(30; disc)
SXT: S(25; disc)
|
vibriostat_129: Res
|